-
Je něco špatně v tomto záznamu ?
No causal association identified for human papillomavirus infections in lung cancer
D. Anantharaman, T. Gheit, T. Waterboer, G. Halec, C. Carreira, B. Abedi-Ardekani, S. McKay-Chopin, D. Zaridze, A. Mukeria, N. Szeszenia-Dabrowska, J. Lissowska, D. Mates, V. Janout, L. Foretova, V. Bencko, P. Rudnai, E. Fabianova, A. Tjønneland,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1941 do Před 1 rokem
Freely Accessible Science Journals
od 1941 do Před 1 rokem
Open Access Digital Library
od 1941-01-01
Open Access Digital Library
od 1941-01-01
- MeSH
- DNA virů analýza genetika MeSH
- dospělí MeSH
- infekce papilomavirem etiologie genetika virologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lidský papilomavirus 11 imunologie MeSH
- lidský papilomavirus 16 imunologie MeSH
- lidský papilomavirus 18 imunologie MeSH
- lidský papilomavirus 6 imunologie MeSH
- nádorové proteiny biosyntéza MeSH
- nádory plic komplikace mortalita virologie MeSH
- onkogenní proteiny virové genetika imunologie MeSH
- Papillomaviridae genetika MeSH
- prospektivní studie MeSH
- protilátky virové imunologie MeSH
- retrospektivní studie MeSH
- RNA virová biosyntéza MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Human papillomavirus (HPV) infections have been implicated in lung carcinogenesis, but causal associations remain uncertain. We evaluated a potential causal role for HPV infections in lung cancer through an analysis involving serology, tumor DNA, RNA, and p16 protein expression. Association between type-specific HPV antibodies and risk of lung cancer was examined among 3,083 cases and 4,328 controls in two case-control studies (retrospective) and one nested case-control study (prospective design). Three hundred and thirty-four available tumors were subjected to pathologic evaluation and subsequent HPV genotyping following stringent conditions to detect all high-risk and two low-risk HPV types. All HPV DNA-positive tumors were further tested for the expression of p16 protein and type-specific HPV mRNA. On the basis of the consistency of the results, although HPV11 and HPV31 E6 antibodies were associated with lung cancer risk in the retrospective study, no association was observed in the prospective design. Presence of type-specific antibodies correlated poorly with the presence of the corresponding HPV DNA in the tumor. Although nearly 10% of the lung tumors were positive for any HPV DNA (7% for HPV16 DNA), none expressed the viral oncogenes. No association was observed between HPV antibodies or DNA and lung cancer survival. In conclusion, we found no supportive evidence for the hypothesized causal association between HPV infections and lung cancer.
Authors' Affiliations Genetic Epidemiology Group
Bureau of Epidemiologic Research Academy of Athens Athens Greece
Cancer Epidemiology Unit Nuffield Department of Clinical Medicine University of Oxford Oxford
Danish Cancer Society Research Center Copenhagen Denmark
Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno
Department of Community Medicine Faculty of Health Sciences The Artic University of Norway Tromsø
Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Lodz
Department of Epidemiology and Prevention Russian Cancer Research Center Moscow Russia
Department of Epidemiology German Institute of Human Nutrition Potsdam Rehbruecke Nuthetal Germany
Department of Gastroenterology and Hepatology University Medical Centre Utrecht the Netherlands
Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden
Department of Preventive Medicine Palacky University Olomouc
Department of Radiation Sciences Oncology Umeå University Umeå
Department of Research Cancer Registry of Norway Oslo Norway
Digestive Disease Research Center Tehran University of Medical Sciences Tehran Iran
Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy
Infection and Cancer Program German Cancer Research Center Heidelberg
Infections and Cancer Biology Group
Institute of Public Health Bucharest Romania
M Sklodowska Curie Memorial Cancer Center and Institute of Oncology Warsaw Poland
Molecular Pathology Group International Agency for Research on Cancer Lyon
National Institute for Public Health and the Environment Bilthoven
National Institute of Environmental Health Budapest Hungary
Public Health Directorate Asturias Spain
Regional Authority of Public Health Banská Bystrica Slovakia
Samfundet Folkhälsan Helsinki Finland
The School of Public health Imperial College London London United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008087
- 003
- CZ-PrNML
- 005
- 20150316114044.0
- 007
- ta
- 008
- 150306s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1158/0008-5472.CAN-13-3548 $2 doi
- 035 __
- $a (PubMed)24760422
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Anantharaman, Devasena $u Authors' Affiliations: Genetic Epidemiology Group; $7 gn_A_00005858
- 245 10
- $a No causal association identified for human papillomavirus infections in lung cancer / $c D. Anantharaman, T. Gheit, T. Waterboer, G. Halec, C. Carreira, B. Abedi-Ardekani, S. McKay-Chopin, D. Zaridze, A. Mukeria, N. Szeszenia-Dabrowska, J. Lissowska, D. Mates, V. Janout, L. Foretova, V. Bencko, P. Rudnai, E. Fabianova, A. Tjønneland, RC. Travis, H. Boeing, JR. Quirós, M. Johansson, V. Krogh, HB. Bueno-de-Mesquita, A. Kotanidou, F. Clavel-Chapelon, E. Weiderpass, M. Johansson, M. Pawlita, G. Scelo, M. Tommasino, P. Brennan,
- 520 9_
- $a Human papillomavirus (HPV) infections have been implicated in lung carcinogenesis, but causal associations remain uncertain. We evaluated a potential causal role for HPV infections in lung cancer through an analysis involving serology, tumor DNA, RNA, and p16 protein expression. Association between type-specific HPV antibodies and risk of lung cancer was examined among 3,083 cases and 4,328 controls in two case-control studies (retrospective) and one nested case-control study (prospective design). Three hundred and thirty-four available tumors were subjected to pathologic evaluation and subsequent HPV genotyping following stringent conditions to detect all high-risk and two low-risk HPV types. All HPV DNA-positive tumors were further tested for the expression of p16 protein and type-specific HPV mRNA. On the basis of the consistency of the results, although HPV11 and HPV31 E6 antibodies were associated with lung cancer risk in the retrospective study, no association was observed in the prospective design. Presence of type-specific antibodies correlated poorly with the presence of the corresponding HPV DNA in the tumor. Although nearly 10% of the lung tumors were positive for any HPV DNA (7% for HPV16 DNA), none expressed the viral oncogenes. No association was observed between HPV antibodies or DNA and lung cancer survival. In conclusion, we found no supportive evidence for the hypothesized causal association between HPV infections and lung cancer.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protilátky virové $x imunologie $7 D000914
- 650 _2
- $a DNA virů $x analýza $x genetika $7 D004279
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidský papilomavirus 11 $x imunologie $7 D052140
- 650 _2
- $a lidský papilomavirus 16 $x imunologie $7 D052162
- 650 _2
- $a lidský papilomavirus 18 $x imunologie $7 D052161
- 650 _2
- $a lidský papilomavirus 6 $x imunologie $7 D052163
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory plic $x komplikace $x mortalita $x virologie $7 D008175
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádorové proteiny $x biosyntéza $7 D009363
- 650 _2
- $a onkogenní proteiny virové $x genetika $x imunologie $7 D009856
- 650 _2
- $a Papillomaviridae $x genetika $7 D027383
- 650 _2
- $a infekce papilomavirem $x etiologie $x genetika $x virologie $7 D030361
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a RNA virová $x biosyntéza $7 D012367
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gheit, Tarik $u Infections and Cancer Biology Group;
- 700 1_
- $a Waterboer, Tim $u Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg;
- 700 1_
- $a Halec, Gordana $u Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg;
- 700 1_
- $a Carreira, Christine $u Molecular Pathology Group, International Agency for Research on Cancer, Lyon;
- 700 1_
- $a Abedi-Ardekani, Behnoush $u Authors' Affiliations: Genetic Epidemiology Group; Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran; $7 gn_A_00000513
- 700 1_
- $a McKay-Chopin, Sandrine $u Infections and Cancer Biology Group;
- 700 1_
- $a Zaridze, David $u Department of Epidemiology and Prevention, Russian Cancer Research Center, Moscow, Russia;
- 700 1_
- $a Mukeria, Anush $u Department of Epidemiology and Prevention, Russian Cancer Research Center, Moscow, Russia;
- 700 1_
- $a Szeszenia-Dabrowska, Neonila $u Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz;
- 700 1_
- $a Lissowska, Jolanta $u M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland;
- 700 1_
- $a Mates, Dana $u Institute of Public Health, Bucharest, Romania;
- 700 1_
- $a Janout, Vladimir $u Department of Preventive Medicine, Palacky University, Olomouc;
- 700 1_
- $a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno;
- 700 1_
- $a Bencko, Vladimir $u Institute of Hygiene and Epidemiology, 1 Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
- 700 1_
- $a Rudnai, Peter $u National Institute of Environmental Health, Budapest, Hungary;
- 700 1_
- $a Fabianova, Eleonora $u Regional Authority of Public Health, Banská Bystrica, Slovakia;
- 700 1_
- $a Tjønneland, Anne $u Danish Cancer Society Research Center, Copenhagen, Denmark;
- 700 1_
- $a Travis, Ruth C $u Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford;
- 700 1_
- $a Boeing, Heiner $u Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany;
- 700 1_
- $a Quirós, J Ramón $u Public Health Directorate, Asturias, Spain;
- 700 1_
- $a Johansson, Mikael $u Department of Radiation Sciences, Oncology, Umeå University, Umeå;
- 700 1_
- $a Krogh, Vittorio $u Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy;
- 700 1_
- $a Bueno-de-Mesquita, H Bas $u The School of Public health, Imperial College London, London, United Kingdom; National Institute for Public Health and the Environment (RIVM), Bilthoven; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands;
- 700 1_
- $a Kotanidou, Anastasia $u First Department of Critical Care Medicine & Pulmonary Services, University of Athens Medical School, Evangelismos Hospital; Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece;
- 700 1_
- $a Clavel-Chapelon, Françoise $u INSERM, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team; University Paris Sud; IGR, Villejuif, France;
- 700 1_
- $a Weiderpass, Elisabete $u Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Community Medicine, Faculty of Health Sciences, The Artic University of Norway, Tromsø; Department of Research, Cancer Registry of Norway, Oslo, Norway; and Samfundet Folkhälsan, Helsinki, Finland.
- 700 1_
- $a Johansson, Mattias $u Authors' Affiliations: Genetic Epidemiology Group;
- 700 1_
- $a Pawlita, Michael $u Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg;
- 700 1_
- $a Scelo, Ghislaine $u Authors' Affiliations: Genetic Epidemiology Group;
- 700 1_
- $a Tommasino, Massimo $u Infections and Cancer Biology Group;
- 700 1_
- $a Brennan, Paul $u Authors' Affiliations: Genetic Epidemiology Group; gep@iarc.fr.
- 773 0_
- $w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 74, č. 13 (2014), s. 3525-34
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24760422 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150316114326 $b ABA008
- 999 __
- $a ok $b bmc $g 1065360 $s 890887
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 74 $c 13 $d 3525-34 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
- LZP __
- $a Pubmed-20150306